Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.
about
P2860
Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparability of Antibody-Medi ...... and the Originator Rituximab.
@en
type
label
Comparability of Antibody-Medi ...... and the Originator Rituximab.
@en
prefLabel
Comparability of Antibody-Medi ...... and the Originator Rituximab.
@en
P2093
P2860
P1433
P1476
Comparability of Antibody-Medi ...... 3 and the Originator Rituximab
@en
P2093
Analía Pesce
Hector A Cuello
Mariano R Gabri
Marina Alberto
Valeria I Segatori
P2860
P2888
P304
P356
10.1007/S40259-016-0171-8
P577
2016-06-01T00:00:00Z